scholarly article | Q13442814 |
P50 | author | Yasuhiro Takahashi | Q81889553 |
Hirohiko Kakizaki | Q81888595 | ||
P2093 | author name string | Makoto Ito | |
Yoshimasa Mori | |||
Kojiro Suzuki | |||
Eisuke Katsuda | |||
Arisa Takeuchi | |||
Yukihiko Oshima | |||
Toshie Mori | |||
Souichirou Abe | |||
P2860 | cites work | Protracted hypofractionated radiotherapy for Graves' ophthalmopathy: a pilot study of clinical and radiologic response | Q84059283 |
Graves' Disease. | Q30243909 | ||
Radiation therapy for benign disease of the orbit | Q33545082 | ||
Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach | Q33647383 | ||
Radiation therapy for Graves' ophthalmopathy: a systematic review and meta-analysis of randomized controlled trials | Q34614078 | ||
Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy | Q36108611 | ||
Understanding diagnostic tests 3: Receiver operating characteristic curves | Q36765868 | ||
Clinical practice. Graves' ophthalmopathy | Q37407540 | ||
Investigation of the freely available easy-to-use software 'EZR' for medical statistics | Q41513106 | ||
Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy | Q42928434 | ||
What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail? | Q43165442 | ||
Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy | Q46585048 | ||
Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy | Q68002641 | ||
Prognostic factors in the radiotherapy of Graves' ophthalmopathy | Q68353384 | ||
Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy | Q73045478 | ||
Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease | Q73101421 | ||
Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy | Q77935435 | ||
Predicting outcome of treatment with radiotherapy in endocrine ophthalmopathy | Q80108991 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 2027 | |
P577 | publication date | 2019-02-14 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Predictive factors of prognosis after radiation and steroid pulse therapy in thyroid eye disease | |
P478 | volume | 9 |
Search more.